L. Leung

Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong

S. Chandwani, J. Pellissier, Carlos K. H. Wong, 2019, PharmacoEconomics - Open.

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma

T. Mok, W. Yeo, E. Hui, 2012, Cancer.

Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong

R. Aguiar-Ibáñez, Carlos K. H. Wong, H. Loong, 2020, Cost Effectiveness and Resource Allocation.

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020, Cost Effectiveness and Resource Allocation.

Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020 .

Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma.

S. Leung, K. C. Chan, Y. Lo, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer—a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria

A. King, B. Ma, F. Mo, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma.

S. Leung, E. Hui, F. Mo, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.